NASDAQ:CMRX - Chimerix, Inc.
$2.45
 $-0.08
-3.16%
4:00PM EDT
2019-08-20
Chimerix, Inc. is a biotechnology company. The Company is focused on discovering, developing and commercializing medicines that address unmet medical needs. Its lead compound, brincidofovir, is in development as an oral and intravenous (IV) formulation for the prevention and treatment of deoxyribonucleic acid (DNA) viruses, including smallpox, adenoviruses (AdV), and the human herpesviruses. It is also advancing the development of CMX521 for the treatment and prevention of norovirus. In addition, the Company has an active discovery program focusing on viral targets for which limited or no therapies are available. Brincidofovir is an investigational oral nucleotide analog that has shown spectrum antiviral activity against all five families of double-stranded deoxyribonucleic acid (dsDNA) viruses that affect humans. Oral and IV formulations of brincidofovir are in development, both of which deliver the active antiviral directly to the site of viral replication. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  CMRX     avg for
industry  
  avg for
sector  
42 stocks weight:  28. 52   0. 00   0. 00  
42 stocks rank:  2. 99 K 1. 09 K 744. 02  
# analyst opinions:  2. 00   12. 93   13. 32  
mean recommendation:  2. 50   2. 12   2. 09  

quick ratio:  11. 55   5. 33   1. 98  
current ratio:  11. 71   5. 72   2. 51  

target price low:  3. 00   79. 69   111. 65  
target price avg:  5. 00   100. 92   134. 03  
target price high:  7. 00   127. 65   152. 12  
1-yr high:  4. 32   105. 44   137. 25  
last close:  2. 45   78. 87   118. 71  
50-day avg:  3. 43   80. 14   119. 68  
200-day avg:  2. 91   82. 14   115. 94  
1-yr low:  1. 79   63. 16   95. 70  
volume:  271. 20 K 3. 02 M 3. 62 M
50-day avg volume:  362. 88 K 3. 81 M 4. 30 M
200-day avg volume:  410. 43 K 3. 21 M 4. 76 M

1-day return:  -3. 16 % -0. 77 % -0. 66 %
this week return:  -2. 00 % 0. 77 % 0. 25 %
12-wk return:  -27. 94 % 4. 28 % 6. 91 %
52-wk return:  -40. 05 % -2. 11 % 5. 10 %

enterprise value (EV):  -4. 07 M 43. 01 B 112. 68 B
market cap:  150. 11 M 502. 93 B 4. 75 T
EBITDA:  -69. 00 M 4. 72 B 7. 97 B
enterprise multiple (EV/EBITDA):  0. 06   2. 49   10. 39  
enterprise/revenue (EV/R):  -0. 45   66. 02   14. 00  
total revenue:  9. 03 M 10. 60 B 32. 65 B
total debt:  1. 16 M 11. 77 B 17. 36 B
debt/equity:  0. 77   242. 17   143. 07  
net income (common):  -66. 38 M 1. 83 B 4. 04 B

shares outstanding:  51. 07 M 568. 69 M 1. 26 B
shares:  39. 39 M 578. 73 M 1. 20 B
shares short:  912. 90 K 15. 55 M 13. 59 M
shares short prior month:  996. 62 K 11. 65 M 12. 17 M
short ratio:  2. 26   6. 99   4. 01  
short % of float:  2. 18 % 7. 00 % 2. 78 %
total cash/share:  2. 58   10. 36   9. 21  
total cash:  158. 40 M 6. 10 B 6. 16 B
free cash flow:  -26. 68 M 2. 88 B 4. 97 B
operating cash flow:  -50. 73 M 4. 06 B 5. 95 B

book value:  2. 91   13. 06   26. 70  
price/book:  0. 84   -1. 46   7. 03  
gross profits:  -48. 02 M 8. 03 B 36. 21 B
operating margins:  -771. 85 % -527. 13 % -123. 82 %
EBITDA margins:  0. 00 % 7. 02 % 24. 14 %
profit margins:  0. 00 % 2. 80 % 14. 63 %
gross margins:  0. 00 % 39. 64 % 57. 79 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 25 % 0. 73 %

1-yr EPS:  -1. 32   1. 29   4. 14  
forward EPS:  -1. 10   3. 32   6. 75  
P/E:  -1. 85   15. 80   23. 34  
forward P/E:  -2. 23   4. 74   18. 22  
PE/G:  -0. 09   1. 14   -1. 53  
growth:  20. 50 % 237. 37 % 108. 53 %
earnings high:  -0. 21   1. 18   1. 64  
earnings avg:  -0. 22   0. 82   1. 51  
earnings low:  -0. 22   0. 53   1. 41  
revenue high:  1. 30 M 2. 85 B 8. 85 B
revenue avg:  900. 00 K 2. 76 B 8. 68 B
revenue low:  500. 00 K 2. 69 B 8. 51 B
return on assets:  -23. 90 % -2. 62 % 5. 63 %
return on equity:  -38. 99 % -25. 81 % 21. 08 %
revenue growth:  20. 50 % 241. 49 % 45. 16 %
revenue/share:  0. 18   13. 13   54. 32  

beta (1yr vs S&P500):  1. 10   1. 22   0. 89  
sharpe (1yr):  -0. 37   0. 18   0. 51  

held % insiders:  2. 47 % 6. 61 % 3. 49 %
held % institutions:  82. 00 % 76. 64 % 68. 97 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-08-20 : CMRX
.     101.33 =          101.33 :: --> INITIAL WEIGHT <--
.    - 1.321 =         100.009 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 1.892 =         189.216 :: P/E factor
.    x 1.823 =         345.009 :: PE/G factor
.     x 1.75 =         603.877 :: beta factor
.    x 0.911 =         550.389 :: sharpe factor
.    x 0.994 =         546.865 :: current ratio factor
.    x 0.873 =         477.244 :: quick ratio factor
.    x 1.254 =         598.515 :: short ratio factor
.    x 1.216 =         727.564 :: revenue growth factor
.    x 1.004 =          730.62 :: price-to-book factor
.    x 2.191 =        1601.071 :: enterprise-to-EBITDA factor
.    x 2.291 =        3668.348 :: enterprise-multiple vs industry factor
.    x 2.632 =        9656.174 :: debt-to-revenue factor
.    x 2.291 =       22124.072 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.715 =       60072.752 :: sector+industry 1-year gains factor
.    x 1.043 =       62641.786 :: industry 12-weeks return factor
.    x 1.312 =       82176.082 :: industry 2-weeks return factor
.    x 1.178 =       96819.023 :: 50-day avg > 200-day avg
.    x 0.991 =       95936.509 :: "drift" penalty 1 days ago
.    x 0.989 =       94839.721 :: "drift" penalty 2 days ago
.    x 0.992 =       94077.493 :: "drift" penalty 5 days ago
.    x 0.928 =       87279.601 :: overall "drift" factor
.    x 0.874 =       76293.001 :: largest single-day price delta factor
.    x 0.068 =         5179.43 :: low price factor
.    x 0.048 =         246.789 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 1.369 =         337.933 :: forward P/E factor
.    x 1.182 =         399.544 :: industry recommendation factor
.    x 1.934 =         772.893 :: company recommendation factor
.    x 1.018 =         787.144 :: factor historical industry gain for week 33
.    x 1.588 =        1249.872 :: target low factor
.     x 1.34 =        1674.913 :: target mean factor
.    x 1.057 =        1770.779 :: target high factor
.    x 8.505 =       15060.271 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =          11.078 :: reduced for readability
.   + 17.442 =           28.52 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                      28.52 :: FINAL WEIGHT for NASDAQ:CMRX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org